Data as of Dec 06
| -0.14 / -4.55%|
The 5 analysts offering 12-month price forecasts for ImmunoCellular Therapeutics Ltd have a median target of 9.00, with a high estimate of 18.00 and a low estimate of 5.00. The median estimate represents a +206.12% increase from the last price of 2.94.
The current consensus among 5 polled investment analysts is to Buy stock in ImmunoCellular Therapeutics Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.